BIOVIIIx Email Formats
Biotechnology Research • 
Naples, Campania, Italy • 21-50 Employees
BIOVIIIx Email Formats
BIOVIIIx uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@bioviiix.com), used 62.2% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@bioviiix.com | 62.2% |
{first initial}.{last name} | j.doe@bioviiix.com | 35.1% |
{first initial}.{second initial}{last name} | j.odoe@bioviiix.com | 2.7% |
Key Contacts at BIOVIIIx
Davide Rosiello
Ceo Bioviiix Gmbh
Monica Mecchia
Medical Affairs Director
Valeria Palmieri
Managing Director
Company overview
| Headquarters | via Alessandro Manzoni, 1, Napoli, Na 80123, IT |
| Phone number | +3905006721210 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Science, Medical, Pharmaceutical, Research, Oncology, Diagnostic, Biotech, Health, Reseller, Innovation, Critical Care, Company, Hospital, Pharma, Hematology, Sanità, Blood, Immunology, Rare Diseases, Salute, Drugs, Proteins, Laboratory, Plasma, Haemostasis, Critical Care, Pathology, Thrombosis, Coagulation, Hemophilia, Rare Disease, Cancer Cure, Orphan Drug, Haemophilia, Market Access, Market Biological Access, Trasfusional, Coagulation Factors, Haemophilia Awareness, Monoclonal, Pathologies, Thrombin Generatiom, Thrombin Generation, Willebrand |
| Founded | 2013 |
| Employees | 21-50 |
| Socials |
About BIOVIIIx
BIOVIIIx is a biotech & pharmaceutical company operating in the field of hemocoagulopathies and rare diseases, with particular specialization in the hemophilia segment. Thanks to the expertise of our management and all our resources, we are able to carry forward a model that combines scientific research with a market approach that stands out for the enormous consideration we reserve for ethical principles and respect. Furthermore, in order to introduce innovative methodologies and tools that improve patient support and with a view to upgrading internal and external business flows, we have chosen to start scientific research initiatives in collaboration with universities, organizations and specialized national and international centers. . A process that starts from the identification of the financing initiatives that are functional to the development of the activity and the best resources available for the success of the same. For these purposes, the BIOVIIIx group is part of today: - AnBition Start Up controlled by BIOVIIIx in collaboration with CNR -IGB - Naples, Italy Startup based in Naples, deals with innovative biotechnological research in the Antitumor field more specifically the projects on which is focused on the inhibition of angiogenesis, the newborn Start Up has filed international patents in this regard and is strongly committed to the development of new pharmaceutical forms and new routes of administration of the developed therapies. - 3P Sense LTD - London Startup based in London, deals with innovative biotechnological research and in 2016 obtained the patent "Cantilever sensors for molecule detection". - Oncovix Startup specialized in cancer research, in 2017 obtained the patent for a new cancer drug "Duo Fix Combination" for pancreatic cancer. #BIOVIIIx
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
BIOVIIIx has 22 employees across 7 departments.
Departments
Number of employees
Funding Data
BIOVIIIx has never raised funding before.
BIOVIIIx Tech Stack
Discover the technologies and tools that power BIOVIIIx's digital infrastructure, from frameworks to analytics platforms.
Security
Hosting
CMS
Miscellaneous
Security
JavaScript frameworks
JavaScript frameworks
Miscellaneous
Japan
United Arab Emirates
South Africa
United States
Canada
India
Netherlands
GermanyFrequently asked questions
4.8
40,000 users
